Originally, uptake-mediated termination of monoamine (e.g., serotonin and dopamine) signalling was believed to only occur via high-affinity, low-capacity transporters ("uptake 1 ") such as the serotonin or dopamine transporters, respectively. Now, the important contribution of a second low-affinity, high-capacity class of biogenic amine transporters has been recognised, particularly in circumstances when uptake 1 transporter function is reduced (e.g., antidepressant treatment). Pharmacologic or genetic reductions in uptake 1 function can change locomotor, anxiety-like or stresscoping behaviours. Comparable behavioural investigations into reduced low-affinity, high-capacity transporter function are lacking, in part, due to a current dearth of drugs that selectively target particular low-affinity, high-capacity transporters, such as the plasma membrane monoamine transporter. Therefore, the most direct approach involves constitutive genetic knockout of these transporters. Other groups have reported that knockout of the low-affinity, high-capacity organic cation transporters 2 or 3 alters anxiety-like and stress-coping behaviours, but none have assessed behaviours in plasma membrane monoamine transporter knockout mice.
| INTRODUCTION
Duration of monoamine neurotransmitter signalling in brain is regulated primarily by active uptake; faster uptake results in shorter signalling duration. Drugs that inhibit monoamine uptake (e.g., cocaine and escitalopram) can have pronounced effects on motor activity, anxiety and/ or mood. Genetic loss of uptake function through knockout of specific transporters in rodents likewise generates animals with altered locomotor, anxiety-like and/or stresscoping phenotypes (see reviews Haenisch & Bönisch, 2011; Commons, Cholanians, Babb, & Ehlinger, 2017) . Through these pharmacologic and genetic means, substantial information has been gained about high-affinity, low-capacity (i.e., uptake 1 ) transporters, including the serotonin, dopamine and norepinephrine transporters (SERT, DAT and NET, respectively) . For example, intensive study of uptake 1 transporters, particularly in knockout mice, has revealed two additional monoamine clearance processes; together, these are aptly termed "uptake 2 " (for review, see Daws, 2009) . One process involves "unfaithful" uptake of monoamines by a different uptake 1 transporter, for example serotonin uptake by DAT (Zhou, Lesch, & Murphy, 2002) and dopamine uptake by NET (Morón, Brockington, Wise, Rocha, & Hope, 2002) . The other process is mediated by a class of low-affinity, high-capacity cation transporters, including the plasma membrane monoamine transporter (PMAT), which is the focus of this study (Baganz et al., 2008; Daws et al., 2006; Schmitt et al., 2003 ) (see Daws, 2009 for review). Herein, reference to the low-affinity, high-capacity biogenic amine transporters consisting of PMAT and the three organic cation transporters (OCTs) will be made using the term "uptake 2 " for the sake of brevity, although we point out that this term also includes "unfaithful" uptake of monoamines by uptake 1 transporters.
Compared to uptake 1 , far less is known about the behavioural consequences of reduced uptake 2 function. In part, this is due to a lack of selective uptake 2 inhibitors. Compounds that inhibit uptake 2 transporters either broadly inhibit PMAT plus OCT1, OCT2 and OCT3 (Horton et al., 2013; Koepsell, Lips, & Volk, 2007; Schömig, BabinEbell, & Russ, 1993) , or have other primary effects that significantly complicate attributing any observed behavioural changes specifically to uptake 2 inhibition. For example, corticosterone is a potent inhibitor of uptake by OCT3, but also elicits a host of both genomic and nongenomic effects through actions at the glucocorticoid receptor (Baganz, Horton, Martin, Holmes, & Daws, 2010; Gasser, 2006; Oakley & Cidlowski, 2013; Wu et al., 1998) . Similarly, lopinavir is selective for PMAT over OCTs (Duan et al., 2015) but has poor bioavailability, particularly in brain, and as a protease inhibitor for treating HIV, its use is further complicated by various undesirable side effects such as metabolic disruptions (Kumar et al., 1999; Patel, Mandava, Gokulgandhi, Pal, & Mitra, 2014; Pistell et al., 2010) . Genetic knockout of uptake 2 transporters therefore currently affords the most straightforward method of understanding how uptake 2 function influences activity and emotion-related behaviours.
Surprisingly few studies, however, have behaviourally characterised mice constitutively lacking an uptake 2 transporter. Mice lacking OCT1, OCT2 or OCT3 were generated over a decade ago (Jonker, Wagenaar, Van Eijl, & Schinkel, 2003; Jonker et al., 2001; Zwart, Verhaagh, Buitelaar, PoppSnijders, & Barlow, 2001) , whereas PMAT was genetically knocked out in mice only a few years ago (Duan & Wang, 2013) . Expression of OCT1 is predominantly in the liver (Jonker et al., 2001; Roth, Obaidat, & Hagenbuch, 2012) , and this may be why OCT1-deficient mice have not, to our knowledge, been behaviourally evaluated. Mice with double knockout of OCT1 and OCT2 are viable (Jonker et al., 2003) , but similarly have not been assessed for behavioural perturbations. Knockout of OCT2 alone in mice reduced anxiety-like behaviours and enhanced passive coping, without affecting overall locomotor activity (Bacq et al., 2012) . Conflicting reports of increased (Vialou et al., 2008) or decreased (Wultsch et al., 2009) anxiety-related behaviours have been reported, in the absence of any locomotor alterations, in mice lacking OCT3. The behavioural consequences of constitutive PMAT deficiency have not yet been examined.
Expression of PMAT is greater in brain than in other organs, and PMAT is more highly expressed in brain than other uptake 2 transporters (Dahlin, Xia, Kong, Hevner, & Wang, 2007; Duan & Wang, 2010; Engel, Zhou, & Wang, 2004; Miura et al., 2017) . Therefore, loss of PMAT function might have more pronounced behavioural effects than those observed in mice lacking an OCT. Moreover, the polyspecific uptake 2 transporters exhibit differential affinities for monoamine neurotransmitters. PMAT preferentially transports serotonin and dopamine, whereas OCTs display higher affinities for histamine, epinephrine and norepinephrine (Duan & Wang, 2010; Miura et al., 2017) . Thus, serotonergic and dopaminergic signalling in brains of PMAT-deficient mice might be prolonged, although this has not yet been directly investigated. Both serotonin and dopamine are strongly implicated in the pathophysiology of neuropsychiatric disorders, particularly depression and anxiety (Chaudhury et al., 2012; Daws, 2009; Fernandez & Gaspar, 2012; Horton et al., 2013; de la Mora, Gallegos-Cari, Arizmendi-García, Marcellino, & Fuxe, 2010; Perona et al., 2008; Russo & Nestler, 2013; Zweifel et al., 2011) . Consequently, we hypothesised that mice with reduced or ablated PMAT function would exhibit disrupted anxiety-like and active-coping behaviours, similar to some reports in constitutive SERT or DAT knockout mice that have prolonged serotonergic or dopaminergic signalling, respectively (Holmes, Li, Murphy, Gold, & Crawley, 2003; Shen et al., 2004; Pogorelov, Rodriguiz, Insco, Caron, & Wetsel, 2005; Perona et al., 2008 ; but see Lira et al., 2003; Weiss et al., 2007; Wellman et al., 2007) . To test this hypothesis, we evaluated the behavioural phenotype of mice constitutively deficient in PMAT using locomotor, anxiety-like and stress-coping measures.
| MATERIALS AND METHODS

| Animals
Mice with targeted disruption of Slc29a4 (PMAT) were generously donated by Dr. Joanne Wang (Duan & Wang, 2013) . Thereafter, all mice were bred in house and maintained on a C57BL/6J background. Mice were housed in a temperature-controlled vivarium maintained at 24°C, on 7090 Teklad sani-chip bedding (Envigo, East Millstone, NJ), and given Teklad LM-485 mouse/rat sterilisable diet 7012 chow (Envigo) and water ad libitum. After weaning, mice were group housed with same sex littermates at 2-5 mice per cage. Adult (≥90 days of age) male and female mice with PMAT alleles intact (+/+), reduced (+/−) or knocked out (−/−) were used for all experiments. Animal numbers ranged from 9 to 25 per sex per genotype; exact Ns for each measure are provided in corresponding figure legends. Food and water were provided ad libitum, and mice were housed in a 12:12 light:dark cycle with lights on at 0800 hr. No procedures involved pain, and every effort was made to minimise the discomfort of the animals. All experiments were approved by the University of Texas Health Science Center at San Antonio Institutional Animal Care and Use Committee, and complied with the National Research Council's Guide for the Care and Use of Laboratory Animals, 8th Ed.
| Genotyping
Genomic DNA was extracted from tail snips or ear punches using Proteinase K (Roche, Basel, Switzerland) in Trissodium dodecyl sulphate-EDTA digestion buffer. PCR analysis of genomic DNA (3.8 μl) was performed in 1× PCR buffer containing 1.74 mM MgCl2 and 34.7 μM dNTPs, with 0.46 μl of Platinum Taq (Invitrogen, Carlsbad, CA) per 22 μl reaction. Primers (Integrated DNA Technologies, Coralville, IA) designed by Duan and Wang (Duan & Wang, 2013) were used for amplification of the wild-type allele, between exons 3 and 4, and/or the knockout allele, at the neomycin resistance gene (Neo): Exon 3 forward-5′ CGA CTA TCT TCA CCA CAA GTA CCC AG 3′; Exon 4 reverse-5′ GAG GCT CAT GTC AAA TAC GAT GGA G 3′; Neo F-5′ CTT GCT CCT GCC GAG AAA GTA TC 3′; and Neo R-5′ TCA GAA GAA CTC GTC AAG AAG GCG 3′. Each PCR proceeded as follows: 95°C for 5-min; 34 cycles of 94°C for 30 s, 59°C for 30 s and 72°C for 90 s; 72°C for 5-min; hold at 4°C. Agarose gel (1%) electrophoresis in Tris-acetate-EDTA buffer was used to visual PCR products, in reference to a 1 kb Plus DNA ladder (Invitrogen, cat. no. 10787018), with the wild-type allele presenting at 847 bp, and the knockout allele at 447 bp (Duan & Wang, 2013) . All genotypes were verified by at least two independent PCR reactions.
| Behaviour testing
In an effort to minimise animal numbers, mice were utilised in at least two different behaviour tests. The first behaviour test was always either the elevated plus maze or locomotor activity. Animals that underwent the marble-burying test did so after one or both of these, and the forced swim test always occurred last to avoid introducing a stress confound on the preceding test(s). Tests were separated by at least 48-hr to minimise carry-over effects of testing on subsequent behavioural evaluations. Males and females were always tested on different days, to further minimise potential behavioural confounds. Mice were moved in their home cages from their colony room to the testing room at least 1-hr prior to test commencement and returned to their colony room at the end of each test.
| Elevated plus maze
Behaviour in the elevated plus maze was assessed under dim white light (44 lux), between 1730 and 2000 hr. The plus maze was constructed of white acrylic, with arms measuring 30 cm long × 5 cm wide, and closed arm walls 15.5 cm high. The floor of the maze was elevated 51 cm off the ground, and all surfaces of the maze were cleaned between each animal with water. Elevated plus maze behaviours were video-recorded for offline analysis with AnyMaze (v5.2; Stoelting, Wood Dale, IL), in which 85% of the animal's entire body area was required to be present in an arm to qualify as an entry. Mice that fell off an open arm during the 5-min test were excluded from analyses (female +/+: 2 of 13 excluded; female +/−: 3 of 12 excluded; female −/−: 5 of 24 excluded; male +/+: 3 of 14 excluded; male +/−: 4 of 22 excluded; and male −/−: 4 of 22 excluded). These incidents are likely attributable to the absence of a ledge surrounding the open arms, which have been added by others to encourage open arm exploration (Rodgers & Johnson, 1995) and minimise falls (Cruz, Frei, & Graeff, 1994; Lee & Rodgers, 1990) in rodents, but consequently can also reduce the aversiveness of the open arms (Fernandes & File, 1996) .
| Locomotor activity
Locomotor activity was assessed using custom activity chambers previously described (Koek, France, & Javors, 2012), containing four equidistant infrared beams spanning the width of clear Plexiglas chambers (15 cm wide × 30 cm long × 15 cm high). Chambers were located in soundattenuating boxes equipped with quiet fans for air circulation. Beam breaks were recorded by Multi-Varimex software (v2.10; Columbus Instruments, Columbus, OH) over a 4-hr span between 1130 and 1530 hr. Faecal boli were counted at test completion, and then all chamber surfaces were cleaned with water.
| Marble-burying test
Marble burying was evaluated as we have previously described (Gould et al., 2011) , as an index of compulsive or repetitive tendencies, and occurred under dim lighting between 1730 and 2000 hr. Briefly, blue decorative marbles were arranged in a 3 × 5 grid pattern atop 5-6 cm of wood chip bedding within a clear acrylic chamber (26 cm wide × 47 cm long × 20 cm high). Mice were then placed in the chamber and left undisturbed for 30-min, at which time pictures of the chambers were taken prior to removal of the mouse, to avoid any disturbance of the bedding. These photographs were used to quantify the number of marbles that were >25% visible; this number was subtracted from 15 to quantify how many marbles were >75% buried.
| Forced swim test
Mice underwent a single, 6-min forced swim between 1200 and 1430 hr in clear acrylic cylinders (19 cm inner diameter × 25 cm high) containing 15 cm of room temperature water (23.5 ± 1.5°C) (Can et al., 2012; Castagné, Moser, Roux, & Porsolt, 2011; Koek, Sandoval, & Daws, 2017) . Tests were video-recorded for offline manual scoring of swimming, immobility and climbing behaviours during the entire 6-min test by an observer blind to genotype and sex using Solomon Coder (beta 17.03.22; solomoncoder.com). Immobility was defined as the absence of all movement, except that minimally necessary to stay afloat, for at least 1 s. Climbing was defined as the mouse being oriented perpendicular to the edge of the cylinder, actively moving both forepaws against the wall and fully extending the hind paws. Swimming was defined as active movement with forward propulsion beyond that necessary to stay afloat, but not meeting the criterion for climbing. After test completion, mice were immediately removed from the water, gently dried with a paper towel and individually placed in clean cages situated half-on a warmed heating pad to facilitate their drying. Faecal boli were counted at test completion, and then, cylinders were rinsed and refilled with clean water for each animal tested.
| Statistical analyses
Locomotor data over time were analysed with a three-way (time × sex × genotype) repeated measures ANOVA, with Geisser-Greenhouse correction for within-subjects analyses, using NCSS (v11.0.13; NCSS, LLC, Kaysville, UT). All other data were analysed with a two-way ANOVA (sex × genotype), with Dunnett's post hoc tests compared with same sex +/+ mice applied where appropriate, using GraphPad Prism (v7.0c; GraphPad Software, La Jolla, CA). Significance was set a priori at p < 0.05, and all data were graphed with GraphPad Prism. Individual data points are shown, along with the mean and SEM.
| RESULTS
| Elevated plus maze
Time spent in the open arms of the elevated plus maze was not significantly different across genotype or sex (Figure 1a) , although a nonsignificant trend was noted for sex (F 1,80 = 3.01, p = 0.09). Evaluation of latency to enter the open arms revealed significant main effects of sex (F 1,80 = 5.58, p = 0.02) and genotype (F 2,80 = 5.01, p = 0.009), but Dunnett's post hoc comparisons did not indicate any significant differences from +/+ mice (Figure 1b) . Similar to open arm time, only a main effect of sex (F 1,80 = 4.47, p = 0.04) was detected for time spent in the closed arms (Figure 1c ). Distance travelled in the entire F I G U R E 2 Locomotor activity is unaltered by PMAT deficiency. Locomotor activity was measured in 5-min bins by infrared beam breaks over a 4-hr consecutive span. (a) Cumulative beam breaks did not differ across sex or genotype. Significant main effects of sex and genotype were detected for (b) faecal boli measured at the conclusion of the locomotor activity assay, but no significant differences were indicated by Dunnett's post hoc tests. A significant interaction between sex and time on locomotor activity was detected, and graphs are separated into (c) female and (d) male data for clarity. (a, b) Means + SEM for wild-type mice are indicated as black bars, heterozygous mice as grey bars and knockout mice as white bars, with individual data points indicated by black squares (wild-types), grey diamonds (heterozygotes) or white circles (knockouts). (c, d) Means ± SEM for each time bin, starting at 5-min, are indicated by black squares and solid black lines (wild-types), grey diamonds and solid grey lines (heterozygotes), or white circles and dashed black lines (knockouts). Ns for all graphs are as follows: wild-types-female N = 16, male N = 19; heterozygotes-female N = 12, male N = 14; knockouts-female N = 25, male N = 21; except in b N = 11 for heterozygous female and N = 22 for knockout female because faecal boli counts were not recorded for four animals elevated plus maze during the 5-min test revealed a significant main effect of genotype (F 2,80 = 7.28, p = 0.001), but relative to +/+ mice, no significant differences were detected by post hoc tests. (Figure 1d ). No significant interactions were detected for any of these measures in the elevated plus maze.
| Locomotor activity
Cumulative locomotor activity, measured by infrared beam breaks in 5-min bins over 4-hr, did not reveal any sex (F 1,101 = 0.131, p = 0.72) or genotype (F 2,101 = 2.04, p = 0.14) differences (Figure 2a ). When examining locomotor activity over time within subjects, there was a significant interaction between sex and time (F 47,4747 =2.24, p = 0.02), but no interaction between genotype and time (F 94,4747 = 1.24, p = 0.22), or between time, sex and genotype (F 94,4747 = 1.20, p = 0.25) (Figure 2c,d ). Significant main effects of sex (F 1,97 = 4.11, p = 0.05) and of genotype (F 2,97 = 3.66, p = 0.03) were detected with respect to faecal boli measured at the conclusion of the 4-hr locomotor test (Figure 2b ), but post hoc tests did not reveal any significant differences relative to +/+ mice within either sex.
| Marble-burying test
With respect to the per cent of marbles buried following 30-min in the marble-burying test (Figure 3) , no significant effect of sex (F 1,95 = 0.850, p = 0.36) or genotype (F 2,95 = 1.58, p = 0.21) was detected.
| Forced swim test
A nonsignificant trend for an interaction between genotype and sex was noted for time spent immobile during the 6-min of the forced swim test (F 2,82 = 2.58, p = 0.08) (Figure 4a) . No main effect of genotype was detected for time spent immobile (F 2,82 = 0.576, p = 0.56), although there was a main effect of sex (F 1,82 = 18.39, p < 0.001) (Figure 4a) . A significant interaction between sex and genotype was observed for the time spent swimming (F 2,82 = 3.12, p = 0.05), and post hoc tests indicated that −/− females swam significantly more than +/+ females (Figure 4b ). In contrast, only main effects of sex were detected for time spent climbing (F 1,82 = 7.48, p = 0.008) (Figure 4c ) and latency to first immobility (F 1,82 = 5.22, p = 0.02) (Figure 4d) . No main effects of sex (F 1,82 = 0.0330, p = 0.86) or genotype (F 2,82 = 0.695, p = 0.50) were observed for total faecal boli at the conclusion of the test (Figure 4e ).
| DISCUSSION
Here, we sought to investigate the behavioural consequences of constitutive PMAT reduction or ablation in mice, as a current lack of PMAT-selective inhibitors devoid of pronounced off-target effects (e.g., the antiretroviral lopinavir) precludes a pharmacological approach. Given previous findings in mice constitutively lacking uptake 1 -mediated transport of serotonin or dopamine, we hypothesised that reductions in PMAT function would similarly perturb anxietyrelated behaviours and active-coping responses. Overall, we found that constitutive deficiency of PMAT exerted remarkably subtle effects on anxiety-related behaviours, produced no significant changes in overall locomotor or compulsive/ repetitive behaviours and sex selectively influenced stresscoping behaviours.
Heterozygous mice appeared to drive the main effects of genotype detected on open arm latency and on total distance travelled in the elevated plus maze. These outcomes indicate a mild enhancement of anxiety-related behaviour across sexes in mice with reduced or ablated PMAT function. Quantification of mobility (swimming and climbing) and immobility in the forced swim test as indicators of active and passive coping behaviour, respectively, revealed that swimming behaviour in the forced swim test was selectively enhanced by PMAT knockout in females. A similar nonsignificant trend for interaction between genotype and sex was noted for time spent immobile. Thus, PMAT ablation specifically increased active-coping behaviour in females but not males. Number of faecal boli, a measure used in rodents to indicate stress (Crumeyrolle-Arias et al., 2014; Taché & Bonaz, 2007) , after the 6-min forced swim test was not different between PMAT genotypes. However, there was a main effect of genotype on faecal boli after 4-hr in the locomotor assay, with PMAT deficiency appearing to reduce faecal boli in a lowstress condition. Given the evidence of PMAT expression in the intestines (Han et al., 2015; Mimura, Yasujima, Ohta, Inoue, & Yuasa, 2017; Wagner, Hu, & Wang, 2016; , this reduced faecal output may be an indicator of altered digestive functionality rather than an indicator of stress response. In sum, constitutive deficiency of PMAT in mice produces remarkably mild effects on anxietyrelated behaviours and enhances active-coping behaviours specifically in female knockouts.
Although these data are the first, to our knowledge, to assess the behavioural repercussions of loss of PMAT function, far more is known about the cellular localisation and function of PMAT. Since discovery of PMAT in 2004 by Wang and colleagues (Engel et al., 2004) , impressive advances have been made in characterising the PMAT protein. The Wang laboratory has extensively assessed how protein domains, membrane potential and extracellular pH affect PMAT kinetic parameters (Itagaki et al., 2012; Zhou, Xia, Engel, et al., 2007) . In PMAT knockout mice generated by the Wang laboratory, they confirmed a prominent role of PMAT in the choroid plexus, where it transports monoamines and other organic cations out of the cerebrospinal fluid (Duan & Wang, 2013) . Multiple research groups have continued to explore cation transport by PMAT at the blood-brain barrier, particularly at the choroid plexus (Duan & Wang, 2013; Hu, Zha, Duan, & Wang, 2017; Okura et al., 2011; Usui et al., 2016; Wu, Lu, Peng, Hsu, & Lin, 2015) . PMAT is also suspected to contribute to intestinal transport and accumulation of cationic drugs, such as metformin and atenolol, and this is supported by in vitro evidence (Han et al., 2015; Mimura et al., 2017; Wagner et al., 2016; . Continued study of PMAT's gastrointestinal contributions, particularly given the reduced defecation that we observed as a function of PMAT deficiency, could expand investigative avenues for this protein beyond drug absorption into the realm of gastrointestinal disorders.
In addition to the unanticipated reduction in defecation by PMAT knockouts following the 4-hr locomotor activity assay, the subtle shifts in anxiety-like behaviours and femalespecific increase in active stress coping were unexpectedly mild. Measures of activity, both in the locomotor assay and in distance travelled in the elevated plus maze, argue that F I G U R E 4 Forced swim test behaviour is moderately altered in female PMAT knockout mice. During a 6-min forced swim test, mice displayed no significant differences in (a) time spent immobile, but a nonsignificant trend (p = 0.08) for an interaction between genotype and sex was noted. A significant interaction was noted for (b) time spent swimming, with post hoc tests revealing increased swimming in female knockouts compared to female wild-types. No significant genotype effects were detected for (c) time spent climbing; (d) latency to the first immobility bout; or (e) faecal boli present at the conclusion of the test. *p < 0.05. Black bars/squares, grey bars/diamonds and white bars/circles indicate wild-type (female N = 17, male N = 12), heterozygous (female N = 11, male N = 13) and knockout (female N = 20, male N = 15) mouse, respectively, means + SEM and individual data points this increased swimming behaviour is not confounded by any overall enhanced activity in female knockouts. Because mice were tested on two or more behaviour measures at least 48-hr apart, a potential for test carry-over effects remains (McIlwain, Merriweather, Yuva-Paylor, & Paylor, 2001) , despite the intentional progression of tests from least to most stressful. Although our behavioural findings only partially support our original hypothesis, they still fit with the current understanding of PMAT and other high-capacity biogenic amine transporters as contributing to more phasic, "as-needed" clearance (see Daws, 2009 ). This overflow engagement of PMAT complements the primary uptake roles of the low-capacity SERT and DAT that are more consistently engaged by tonic signalling conditions. Importantly, PMAT knockout mice do not display compensatory changes in blood chemistry or in whole brain SERT, DAT, NET or OCT3 mRNA expression (Duan & Wang, 2013) , suggesting the increased active-coping behaviour observed in females is likely not a consequence of compensatory upregulation of other transporters. However, brain region-specific expression levels and function of monoamine transporters have not yet been quantified in PMAT-deficient mice, so a possibility remains for more localised compensatory upregulation. Alternatively, the modest anxiety-related perturbations noted in heterozygotes, but not knockouts, could suggest recruitment of an asyet-unidentified transporter in the latter. This might explain why knockout behaviour more closely resembles that of wildtypes in the elevated plus maze, whereas partial deletion of PMAT in heterozygotes might not be sufficient to elicit this compensatory upregulation and thereby could reveal a more accurate representation of constitutive PMAT deficiency. Such mice could provide valuable models of reduced PMAT function (Shirasaka et al., 2017) , as recently two SLC29A4 polymorphisms conferring loss of function have been discovered in humans (Adamsen et al., 2014) . Indeed, deficiency of PMAT may not become overtly evident in behaviours until monoaminergic systems are sufficiently perturbed. Future studies that evaluate how these mice perform under conditioned behavioural paradigms (e.g., drug self-administration) or respond to chronic stressors could unmask the necessity of PMAT as a compensatory monoamine transporter.
The importance of monoamine neurotransmitter uptake by transporters is underscored by marked psychological and behavioural effects resulting from reductions in their function. For example, uptake 1 inhibitors such as cocaine, methylphenidate, bupropion, venlafaxine and citalopram can induce changes in cognition, impulse control, alertness, mood and anxiety (for review, see Liu & Molino, 2007; Daws, 2009; Haenisch & Bönisch, 2011) . Likewise, genetic knockout of uptake 1 transporters in mice and rats alters anxiety-and depressive-like behaviours, and changes responses to cognitive tasks or rewarding drugs (Holmes et al., 2003; Shen et al., 2004; Perona et al., 2008 ; see Haenisch & Bönisch, 2011 for review). Such phenotypes, however, are sometimes at least partially moderated by compensatory upregulation of other biogenic amine transporters, such as by OCT3 in SERT heterozygous and knockout mice (Baganz et al., 2008) , and by SERT and DAT in NET knockout mice (Solich et al., 2011) . This moderation, which could be strain-, species-and even context-dependent, might help explain discrepancies within the uptake 1 knockout literature regarding directionality of anxiety-like and active-coping behavioural changes elicited by SERT or DAT deletion (Holmes et al., 2003; Lira et al., 2003; Olivier et al., 2008; Perona et al., 2008; Pogorelov et al., 2005; Weiss et al., 2007; Wellman et al., 2007) . Certainly, behaviour in constitutive genetic knockouts does not necessarily correspond to the behavioural consequences of transient pharmacologic transporter inhibition. For example, the elevated anxiety-like phenotype of constitutive SERT knockout rodents (Holmes et al., 2003; Olivier et al., 2008) (but see Lira et al., 2003) contrasts with the robust effectiveness of SERT-inhibiting drugs in treating anxiety in adults (Bandelow et al., 2015) . Constitutive reduction or knockout of specific monoamine transporters nonetheless provides valuable information about compromised transporter function, compensatory processes, monoamine signalling dynamics, and physiological and behavioural sequelae that can help direct future studies. 
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